Angiotensin-converting enzyme inhibitors will not help in improving stroke outcome if given immediately after stroke.

Angiotensin-receptor blockade in acute stroke. Ann Indian Acad Neurol (2011) 0.75

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA (2002) 36.26

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 29.25

Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med (2008) 19.76

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet (2001) 17.97

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet (1999) 7.56

Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet (2008) 7.05

Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet (1996) 3.95

Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol (2008) 1.87

Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology (2003) 1.78

Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up. Am J Hypertens (2007) 1.54

Angiotensin-converting enzyme inhibitors for stroke prevention: is there HOPE for PROGRESS After LIFE? Stroke (2003) 1.44

Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome? Neurology (2007) 0.98

Effect of pre-stroke use of ACE inhibitors on ischemic stroke severity. BMC Neurol (2005) 0.98

Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk. Neurology (2006) 0.87

Preventing stroke: the PRoFESS, ONTARGET, and TRANSCEND trial programs. J Hypertens Suppl (2009) 0.83

Antihypertensive treatment and stroke prevention: from recent meta-analyses to the PRoFESS trial. Curr Hypertens Rep (2009) 0.82

Usefulness and safety of early blood pressure lowering after ischemic stroke still unproven. Am J Hypertens (2007) 0.79

Blood pressure in acute stroke: lower it or let the CHHIPS fall where they will. Lancet Neurol (2008) 0.79

Lessons learned from the ONTARGET and TRANSCEND trials. Curr Atheroscler Rep (2009) 0.79

Perindopril: do randomised, controlled trials support an ACE inhibitor class effect? A meta-analysis of clinical trials. Cardiovasc J Afr (2009) 0.78

Prevention of major cardiovascular events with an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker early or late after stroke. J Hypertens Suppl (2009) 0.78